Clinical Trial Update: Botulinum Toxin Injection Into Epicardial Fat Pads to Prevent Atrial Fibrillation in Patients Undergoing Cardiac Surgery [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on botulinum toxin injection into epicardial fat pads to prevent atrial fibrillation in patients undergoing cardiac surgery; phases 2 and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Meshalkin Research Institute of Pathology of Circulation | Conditions: Atrial Fibrillation | Phase 2, Phase 3 | Status: UNKNOWN